D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 106 Citations 50,057 639 World Ranking 2823 National Ranking 122

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Mutation

His scientific interests lie mostly in Internal medicine, Endocrinology, Genetics, Cholesterol and Diabetes mellitus. His Internal medicine study combines topics in areas such as Allele frequency and Cardiology. His Cardiology study integrates concerns from other disciplines, such as Pediatrics and Genetic testing.

As a part of the same scientific family, Robert A. Hegele mostly works in the field of Genetics, focusing on Apolipoprotein B and, on occasion, Microsomal triglyceride transfer protein and Exome sequencing. Robert A. Hegele works mostly in the field of Cholesterol, limiting it down to topics relating to Polymorphism and, in certain cases, SNP. His biological study spans a wide range of topics, including Odds ratio and Kidney disease.

His most cited work include:

  • Biological, clinical and population relevance of 95 loci for blood lipids (2804 citations)
  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society (1430 citations)
  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel (944 citations)

What are the main themes of his work throughout his whole career to date?

Robert A. Hegele mostly deals with Internal medicine, Genetics, Endocrinology, Cholesterol and Gene. Robert A. Hegele has researched Internal medicine in several fields, including Diabetes mellitus and Cardiology. His Mutation, Single-nucleotide polymorphism, Phenotype, Allele and Candidate gene study are his primary interests in Genetics.

His Endocrinology research integrates issues from Familial partial lipodystrophy and Genotype. Robert A. Hegele works in the field of Cholesterol, focusing on Ezetimibe in particular. Robert A. Hegele is interested in Genetic variation, which is a branch of Gene.

He most often published in these fields:

  • Internal medicine (50.49%)
  • Genetics (36.97%)
  • Endocrinology (37.84%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (50.49%)
  • Genetics (36.97%)
  • Endocrinology (37.84%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Genetics, Endocrinology, Familial hypercholesterolemia and Cholesterol are his primary areas of study. His research in Internal medicine intersects with topics in Gastroenterology and Cardiology. Robert A. Hegele specializes in Endocrinology, namely Apolipoprotein B.

His Familial hypercholesterolemia research is multidisciplinary, incorporating perspectives in Dyslipidemia and Lipoprotein. Robert A. Hegele interconnects Inflammation and Diabetes mellitus in the investigation of issues within Cholesterol. His work in the fields of Gene, such as Genetic variation, Genetic predisposition and Allele, intersects with other areas such as Lipodystrophy.

Between 2018 and 2021, his most popular works were:

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (135 citations)
  • The complex molecular genetics of familial hypercholesterolaemia. (74 citations)
  • Lipid-Lowering Agents. (66 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Mutation

Robert A. Hegele mainly focuses on Internal medicine, Genetic testing, Hypertriglyceridemia, Dyslipidemia and Genetics. His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Cardiology. Robert A. Hegele has included themes like Mipomersen and Alipogene tiparvovec in his Endocrinology study.

Robert A. Hegele combines subjects such as Single-nucleotide polymorphism, Compound heterozygosity and Fatty acid with his study of Hypertriglyceridemia. The concepts of his Dyslipidemia study are interwoven with issues in Receptor, Familial hypercholesterolemia, Sequence analysis and Familial Chylomicronemia. The Gene, Copy-number variation, Phenotype and Transcription factor research Robert A. Hegele does as part of his general Genetics study is frequently linked to other disciplines of science, such as Nuclear lamina, therefore creating a link between diverse domains of science.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Biological, clinical and population relevance of 95 loci for blood lipids

Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson.
Nature (2010)

3230 Citations

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg.
European Heart Journal (2013)

2341 Citations

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray.
European Heart Journal (2017)

1461 Citations

Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

Sonia S Anand;Salim Yusuf;Vladmir Vuksan;Sudarshan Devanesen.
The Lancet (2000)

1250 Citations

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu.
European Heart Journal (2015)

1051 Citations

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

Jacques Genest;Ruth McPherson;Jiri Frohlich;Todd Anderson.
Canadian Journal of Cardiology (2009)

1002 Citations

2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

Todd J. Anderson;Jean Grégoire;Robert A. Hegele;Patrick Couture.
Canadian Journal of Cardiology (2013)

952 Citations

Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy

Henian Cao;Robert A. Hegele.
Human Molecular Genetics (2000)

726 Citations

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

Todd J. Anderson;Jean Grégoire;Glen J. Pearson;Arden R. Barry.
Canadian Journal of Cardiology (2016)

694 Citations

Hypertriglyceridemia: its etiology, effects and treatment

George Yuan;Khalid Z. Al-Shali;Robert A. Hegele.
Canadian Medical Association Journal (2007)

666 Citations

Editorial Boards

Current Opinion in Lipidology
(Impact Factor: 4.616)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert A. Hegele

Gerald F. Watts

Gerald F. Watts

University of Western Australia

Publications: 278

Daniel J. Rader

Daniel J. Rader

University of Pennsylvania

Publications: 185

Sekar Kathiresan

Sekar Kathiresan

Harvard University

Publications: 180

Eric Boerwinkle

Eric Boerwinkle

The University of Texas Health Science Center at Houston

Publications: 159

Maciej Banach

Maciej Banach

Medical University of Lodz

Publications: 149

Børge G. Nordestgaard

Børge G. Nordestgaard

Copenhagen University Hospital

Publications: 143

Steve E. Humphries

Steve E. Humphries

University College London

Publications: 129

Alberico L. Catapano

Alberico L. Catapano

University of Milan

Publications: 124

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 122

J. David Spence

J. David Spence

University of Western Ontario

Publications: 122

Bruce M. Psaty

Bruce M. Psaty

University of Washington

Publications: 120

John J.P. Kastelein

John J.P. Kastelein

University of Amsterdam

Publications: 117

Paul M. Ridker

Paul M. Ridker

Harvard Medical School

Publications: 114

Jerome I. Rotter

Jerome I. Rotter

Los Angeles Biomedical Research Institute

Publications: 113

Jose M. Ordovas

Jose M. Ordovas

Tufts University

Publications: 109

Nilesh J. Samani

Nilesh J. Samani

University of Leicester

Publications: 106

Trending Scientists

Franz Hlawatsch

Franz Hlawatsch

TU Wien

Hai Zhao

Hai Zhao

Shanghai Jiao Tong University

Andrew T. Duchowski

Andrew T. Duchowski

Clemson University

Hujun Bao

Hujun Bao

Zhejiang University

Eric Williams

Eric Williams

Rochester Institute of Technology

Carol J. Bult

Carol J. Bult

European Bioinformatics Institute

Douglas F. Levinson

Douglas F. Levinson

Stanford University

George Harauz

George Harauz

University of Guelph

Ikumi Tamai

Ikumi Tamai

Kanazawa University

Regina C. LaRocque

Regina C. LaRocque

Harvard University

Masahiro Iwamoto

Masahiro Iwamoto

University of Maryland, Baltimore

Devendra K. Agrawal

Devendra K. Agrawal

Western University of Health Sciences

Sunder Mudaliar

Sunder Mudaliar

University of California, San Diego

Richard F. Keep

Richard F. Keep

University of Michigan–Ann Arbor

Daniel P. Judge

Daniel P. Judge

Medical University of South Carolina

Something went wrong. Please try again later.